PL426821A1 - Peptide, application of this peptide and a composition that contains this peptide - Google Patents

Peptide, application of this peptide and a composition that contains this peptide

Info

Publication number
PL426821A1
PL426821A1 PL426821A PL42682112A PL426821A1 PL 426821 A1 PL426821 A1 PL 426821A1 PL 426821 A PL426821 A PL 426821A PL 42682112 A PL42682112 A PL 42682112A PL 426821 A1 PL426821 A1 PL 426821A1
Authority
PL
Poland
Prior art keywords
peptide
composition
application
sequence
ovalbumin
Prior art date
Application number
PL426821A
Other languages
Polish (pl)
Other versions
PL233101B1 (en
Inventor
Marta Pokora
Ewelina Eckert
Aleksandra Zambrowicz
Anna Dąbrowska
Marek SZOŁTYSIK
Józefa Chrzanowska
Antoni Polanowski
Tadeusz Trziszka
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL426821A priority Critical patent/PL233101B1/en
Publication of PL426821A1 publication Critical patent/PL426821A1/en
Publication of PL233101B1 publication Critical patent/PL233101B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem wynalazku jest peptyd zawierający sekwencję Asp-Ile-Leu-Asn, odpowiadający fragmentowi 86-89 owoalbuminy. Uzyskany peptyd wykazuje aktywność przeciwutleniającą poprzez wiązanie wolnych rodników oraz chelatowanie kationów dwuwartościowych. Sekwencja peptydu, ze względu na swoje właściwości, może być szeroko wykorzystana zarówno w przemyśle farmaceutycznym, spożywczym i kosmetycznym.The present invention relates to a peptide comprising the sequence Asp-Ile-Leu-Asn, corresponding to fragment 86-89 of ovalbumin. The resulting peptide has antioxidant activity by binding free radicals and chelating divalent cations. The peptide sequence, due to its properties, can be widely used in both the pharmaceutical, food and cosmetics industries.

PL426821A 2012-10-01 2012-10-01 Peptide, application of this peptide and a composition that contains this peptide PL233101B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL426821A PL233101B1 (en) 2012-10-01 2012-10-01 Peptide, application of this peptide and a composition that contains this peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL426821A PL233101B1 (en) 2012-10-01 2012-10-01 Peptide, application of this peptide and a composition that contains this peptide

Publications (2)

Publication Number Publication Date
PL426821A1 true PL426821A1 (en) 2018-11-05
PL233101B1 PL233101B1 (en) 2019-09-30

Family

ID=63998354

Family Applications (1)

Application Number Title Priority Date Filing Date
PL426821A PL233101B1 (en) 2012-10-01 2012-10-01 Peptide, application of this peptide and a composition that contains this peptide

Country Status (1)

Country Link
PL (1) PL233101B1 (en)

Also Published As

Publication number Publication date
PL233101B1 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
MX2021010033A (en) Microencapsulated cannabinoid compositions.
PH12015502553A1 (en) Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
EA201690314A1 (en) ANTI-GARP-PROTEIN AND ITS APPLICATIONS
MX371497B (en) Compositions and methods comprising a lipolytic enzyme variant.
MX2015011075A (en) Therapeutic peptides.
PH12014501942A1 (en) Cereal pieces containing alpha-linolenic acid
MX2020009223A (en) Afucosylated anti-fgfr2iiib antibodies.
EA201490644A1 (en) THERAPEUTIC PEPTIDES
IN2015DN03322A (en)
EA201492221A1 (en) POLYPEPTIDES THAT HAVE A TRANSGALACTOSIS ACTIVITY
MX2018000590A (en) Antibody molecules which bind cd79.
HUE038906T2 (en) Caseinomacropeptide-containing, high protein denatured whey protein compositions, products containing them, and uses thereof
MX2017012596A (en) A pharmaceutical composition and the use thereof.
MX350970B (en) Methods and compositions for extending shelf life of plant products.
BR112015027824A2 (en) vitamin e powder compositions
FR2977256B1 (en) COMPOSITIONS OF 2,4,4,4-TETRAFLUOROBUT-1-ENE AND CIS-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE
PH12015501099A1 (en) Synbiotic composition and use thereof
NZ717927A (en) Compositions for the treatment of hypertension and/or fibrosis
ZA201504748B (en) New antibody fragments, compositions and uses thereof
MX2014009244A (en) A composition and use thereof in the treatment of anal rhagades.
EP2569327A4 (en) Eif4e binding peptides
PH12015501147A1 (en) Synbiotic composition and use thereof
PL426821A1 (en) Peptide, application of this peptide and a composition that contains this peptide
MX2015009385A (en) Compositions comprising heat-treated clear tomato concentrate.
MX2018005783A (en) Hemostatic composition.